Literature DB >> 6116857

Malignant melanoma among employees of Lawrence Livermore National Laboratory.

D F Austin, P J Reynolds, M A Snyder, M W Biggs, H A Stubbs.   

Abstract

19 cases of malignant melanoma (MM) were observed during 1972-77 among approximately 5100 employees of the Lawrence Livermore National Laboratory, where high energy physics research is conducted. This number was significantly higher (p less than 2 X 10(-6)) than that expected in a comparable age/race/sex/geographical segment of the population of the San Francisco Bay Area. The excess seemed to occur only among laboratory employees and not among the surrounding community, which suggests that an occupational factor is responsible. Preliminary case-comparison findings suggest that MM risk is not associated with length of employment at the laboratory nor with type of monitored radiation exposure. Although the data did not support an association between MM incidence and all scientific job classifications combined, an excess relative risk was observed among chemists. The reasons for the MM excess have not been identified.

Entities:  

Mesh:

Year:  1981        PMID: 6116857     DOI: 10.1016/s0140-6736(81)91047-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Mortality experience of electrical engineers.

Authors:  R Olin; D Vågerö; A Ahlbom
Journal:  Br J Ind Med       Date:  1985-03

2.  Cancer incidence among employees of the Lawrence Livermore National Laboratory, 1969-1980.

Authors:  P Reynolds; D F Austin
Journal:  West J Med       Date:  1985-02

3.  Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.

Authors:  G Gong; A S Whittemore; D West; D H Moore
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

4.  Increased incidence of malignant melanoma of the skin in workers in a telecommunications industry.

Authors:  L De Guire; G Theriault; H Iturra; S Provencher; D Cyr; B W Case
Journal:  Br J Ind Med       Date:  1988-12

5.  Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.

Authors:  J N Howell; M H Greene; R C Corner; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden.

Authors:  D Vågerö; A J Swerdlow; V Beral
Journal:  Br J Ind Med       Date:  1990-05

7.  Cancer morbidity among workers in the telecommunications industry.

Authors:  D Vågerö; A Ahlbom; R Olin; S Sahlsten
Journal:  Br J Ind Med       Date:  1985-03

8.  Melanoma screening in a hungarian nuclear power plant.

Authors:  Veronika Tóth; Beáta Somlai; Zsófia Hatvani; József Szakonyi; István Gaudi; Sarolta Kárpáti
Journal:  Pathol Oncol Res       Date:  2012-12-15       Impact factor: 3.201

9.  Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia.

Authors:  D R English; B K Armstrong
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

10.  Malignant melanoma of the skin among workers in a telecommunications industry: mortality study 1976-83.

Authors:  L DeGuire; D Cyr; G Thériault; S Provencher; H Iturra; B W Case
Journal:  Br J Ind Med       Date:  1992-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.